To explore the above issues, we have examined the effects of overexpression of the full length and variant versions of TSPX in the prostate cancer cell line LNCaP, and determined the respective effects in cell viability, morphology and gene expression patterns using RNA-Seq strategy. Here, TSPYL2 is linked to prostate cancer.